Okabe et al. [21] using intraintestinal and intraportal administration of tacrolimus estimated contribution of intestinal P-gp to tacrolimus pharmacokinetics in kidney failure induced by intraperitoneal administration of cisplatin. The gene discussed is PGP; the disease is kidney failure.